These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31988039)

  • 1. Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image Guided Stereotactic Body Radiation Therapy in the Abdomen.
    Slagowski JM; Colbert LE; Cazacu IM; Singh BS; Martin R; Koay EJ; Taniguchi CM; Koong AC; Bhutani MS; Herman JM; Beddar S
    Pract Radiat Oncol; 2020; 10(6):434-442. PubMed ID: 31988039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of optimal fiducial marker across image-guided radiation therapy (IGRT) modalities: visibility and artifact analysis of gold, carbon, and polymer fiducial markers.
    Handsfield LL; Yue NJ; Zhou J; Chen T; Goyal S
    J Appl Clin Med Phys; 2012 Sep; 13(5):3976. PubMed ID: 22955665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative evaluation of fiducial markers for radiotherapy imaging.
    Chan MF; Cohen GN; Deasy JO
    Technol Cancer Res Treat; 2015 Jun; 14(3):298-304. PubMed ID: 25230715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification and comparison of visibility and image artifacts of a new liquid fiducial marker in a lung phantom for image-guided radiation therapy.
    Scherman Rydhög J; Irming Jølck R; Andresen TL; Munck Af Rosenschöld P
    Med Phys; 2015 Jun; 42(6):2818-26. PubMed ID: 26127034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
    Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
    Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
    De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
    Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel artifact-robust and highly visible zinc solid fiducial marker for kilovoltage x-ray image-guided radiation therapy.
    Wang T; Inubushi S; Ikeo N; Mukai T; Okumura K; Akasaka H; Yada R; Yoshida K; Miyawaki D; Ishihara T; Nakaoka A; Sasaki R
    Med Phys; 2020 Oct; 47(10):4703-4710. PubMed ID: 32696571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a pancreas tissue-mimicking phantom.
    Schneider S; Jølck RI; Troost EGC; Hoffmann AL
    Med Phys; 2018 Jan; 45(1):37-47. PubMed ID: 29136287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visibility of fiducial markers used for image-guided radiation therapy on optical coherence tomography for registration with CT: An esophageal phantom study.
    Jelvehgaran P; Alderliesten T; Weda JJA; de Bruin M; Faber DJ; Hulshof MCCM; van Leeuwen TG; van Herk M; de Boer JF
    Med Phys; 2017 Dec; 44(12):6570-6582. PubMed ID: 29023771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer.
    Cheung J; Kudchadker RJ; Zhu XR; Lee AK; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):7135-47. PubMed ID: 21076190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical investigation for developing injectable fiducial markers using a mixture of BaSO4 and biodegradable polymer for proton therapy.
    Ahn SH; Gil MS; Lee DS; Han Y; Park HC; Sohn JW; Kim HY; Shin EH; Yu JI; Noh JM; Cho JS; Ahn SH; Choi DH
    Med Phys; 2015 May; 42(5):2626-37. PubMed ID: 25979054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
    Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of computed tomography metal artifact and CyberKnife fiducial recognition for novel size fiducial markers.
    Nemoto H; Saito M; Suzuki T; Suzuki H; Sano N; Mochizuki Z; Mochizuki K; Ueda K; Komiyama T; Marino K; Aoki S; Oguri M; Takahashi H; Onishi H
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14142. PubMed ID: 37672211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
    Singhrao K; Ruan D; Fu J; Gao Y; Chee G; Yang Y; King C; Hu P; Kishan AU; Lewis JH
    Phys Med Biol; 2020 Feb; 65(3):035015. PubMed ID: 31881546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fiducial visibility on planar images during motion-synchronized tomotherapy treatments.
    Ferris WS; DeWerd LA; Culberson WS
    Biomed Phys Eng Express; 2022 Jan; 8(2):. PubMed ID: 35026743
    [No Abstract]   [Full Text] [Related]  

  • 16. Fiducial markers: can the urologist do better?
    Duncan C; Joon DL; Lawrentschuk N; Jenkins T; Schneider M; Khoo V; Chao M; Lawlor M; O'Meara R; Berry C; Viotto A; Brown K; Wada M; Foroudi F; Sengupta S
    World J Urol; 2019 Jul; 37(7):1281-1287. PubMed ID: 30288597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer.
    van den Ende RPJ; Rigter LS; Kerkhof EM; van Persijn van Meerten EL; Rijkmans EC; Lambregts DMJ; van Triest B; van Leerdam ME; Staring M; Marijnen CAM; van der Heide UA
    Radiother Oncol; 2019 Mar; 132():93-99. PubMed ID: 30825976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving metal artifact reduction in cone-beam CT scans with implanted cylindrical gold markers.
    Toftegaard J; Fledelius W; Seghers D; Huber M; Brehm M; Worm ES; Elstrøm UV; Poulsen PR
    Med Phys; 2014 Dec; 41(12):121710. PubMed ID: 25471957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential position errors using fiducial markers for gated image guided radiotherapy.
    Nielsen MS; Nyström MW; Carl J
    Acta Oncol; 2013 Oct; 52(7):1472-6. PubMed ID: 23984813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Gold Fiducial Markers as a Surrogate for Gross Tumor Volume Position in Image-Guided Radiation Therapy of Rectal Cancer.
    van den Ende RPJ; Kerkhof EM; Rigter LS; van Leerdam ME; Peters FP; van Triest B; Staring M; Marijnen CAM; van der Heide UA
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1151-1159. PubMed ID: 31476419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.